CN101843661B - Chinese medicament for treating angina - Google Patents

Chinese medicament for treating angina Download PDF

Info

Publication number
CN101843661B
CN101843661B CN2009100937066A CN200910093706A CN101843661B CN 101843661 B CN101843661 B CN 101843661B CN 2009100937066 A CN2009100937066 A CN 2009100937066A CN 200910093706 A CN200910093706 A CN 200910093706A CN 101843661 B CN101843661 B CN 101843661B
Authority
CN
China
Prior art keywords
chinese medicine
chinese medicament
chinese
fine powder
parts
Prior art date
Application number
CN2009100937066A
Other languages
Chinese (zh)
Other versions
CN101843661A (en
Inventor
刘新壮
Original Assignee
北京绿源求证科技发展有限责任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京绿源求证科技发展有限责任公司 filed Critical 北京绿源求证科技发展有限责任公司
Priority to CN2009100937066A priority Critical patent/CN101843661B/en
Publication of CN101843661A publication Critical patent/CN101843661A/en
Application granted granted Critical
Publication of CN101843661B publication Critical patent/CN101843661B/en

Links

Abstract

The invention relates to a Chinese medicament for treating angina, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: rosewood heart wood, radix pseudo-ginseng, root of red-rooted salvia, lucid ganoderma and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and rectifying qi and relieving pain, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

The anginal Chinese medicine of a kind of treatment
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Present be intended to treat the anginal field of Chinese medicines, exist some problems: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that many patient with angina pectoris are subjected to the torment of feeling of oppression and pain in the chest for a long time, the probability that myocardial infarction takes place increases, and has influenced life quality.
At problem set forth above, the invention provides the anginal Chinese medicine of a kind of treatment, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, the anginal Chinese medicine of a kind of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Lignum Dalbergiae Odoriferae 3---30 parts of 20 portions of Radix Notoginseng 3---20 parts of Radix Salviae Miltiorrhizaes 4---
Ganoderma 2---15 parts
The anginal Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Lignum Dalbergiae Odoriferae, Radix Salviae Miltiorrhizae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma vigorate qi and replenish the blood in the side, tranquilizing by nourishing the heart has the body resistance strengthening and constitution consolidating, regulates the immunity of organisms effect; Radix Salviae Miltiorrhizae, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; Assistant is with the hemostasis of Lignum Dalbergiae Odoriferae clots absorbing, the analgesia of regulating the flow of vital energy.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of regulating QI to relieve pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Lignum Dalbergiae Odoriferae 60 gram Radix Notoginseng 60 gram Radix Salviae Miltiorrhizaes 80 grams
Ganoderma 40 grams
Weight in accordance with regulations, with conventional water extraction process Lignum Dalbergiae Odoriferae, Radix Salviae Miltiorrhizae are extracted, make extractum fine powder 42 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 507 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Lignum Dalbergiae Odoriferae 100 gram Radix Notoginseng 100 gram Radix Salviae Miltiorrhizaes 160 grams
Ganoderma 70 grams
By above-mentioned same method, make 885 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Lignum Dalbergiae Odoriferae 200 gram Radix Notoginseng 200 gram Radix Salviae Miltiorrhizaes 300 grams
Ganoderma 150 grams
By above-mentioned same method, make 1785 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
8 parts of 5 parts of Radix Salviae Miltiorrhizaes of 4 portions of Radix Notoginseng of Lignum Dalbergiae Odoriferae
3 parts of Ganodermas
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
25 parts of 15 parts of Radix Salviae Miltiorrhizaes of 15 portions of Radix Notoginseng of Lignum Dalbergiae Odoriferae
10 parts of Ganodermas
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science angina pectoris, through 8 routine clinical observations.Selecting the tcm diagnosis angina pectoris is standard: feeling of oppression and pain in the chest, and nervous cardiopalmus, limbs fatigue, the visible T ripple of electrocardiogram is unusual during outbreak.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 5 examples, women's 3 examples do not have other serious disease, and the age is 46 years old-77 years old, 62.4 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and heart district is comfortable, and angor uncomfortable in chest is obviously alleviated or disappeared, and Electrocardioscopy is no abnormal.
2, effective: body constitution strengthens to some extent, and angor uncomfortable in chest is alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.8 philtrums of clinical experiment, produce effects 4 people, effective 3 people, invalid 1 people, total effective rate 87.5%.

Claims (1)

1. the anginal Chinese medicine of treatment is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Lignum Dalbergiae Odoriferae 3---30 parts of 20 portions of Radix Notoginseng 3---20 parts of Radix Salviae Miltiorrhizaes 4---
Ganoderma 2---15 parts
The anginal Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Lignum Dalbergiae Odoriferae, Radix Salviae Miltiorrhizae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, capsule, watered pill, Tabules.
CN2009100937066A 2009-09-25 2009-09-25 Chinese medicament for treating angina CN101843661B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100937066A CN101843661B (en) 2009-09-25 2009-09-25 Chinese medicament for treating angina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100937066A CN101843661B (en) 2009-09-25 2009-09-25 Chinese medicament for treating angina

Publications (2)

Publication Number Publication Date
CN101843661A CN101843661A (en) 2010-09-29
CN101843661B true CN101843661B (en) 2011-08-10

Family

ID=42768596

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100937066A CN101843661B (en) 2009-09-25 2009-09-25 Chinese medicament for treating angina

Country Status (1)

Country Link
CN (1) CN101843661B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102389493A (en) * 2011-07-23 2012-03-28 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic heart disease
CN102380032A (en) * 2011-08-14 2012-03-21 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic heart disease
CN102389494A (en) * 2011-09-03 2012-03-28 北京绿源求证科技发展有限责任公司 Chinese medicine for treating diabetic heart diseases
CN102379980A (en) * 2011-09-16 2012-03-21 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic heart diseases
CN102379981A (en) * 2011-09-27 2012-03-21 北京绿源求证科技发展有限责任公司 Chinese medicament for treating diabetic heart disease
CN102327387A (en) * 2011-10-10 2012-01-25 北京绿源求证科技发展有限责任公司 Chinese medicine for treating diabetic heart disease
CN107456481A (en) * 2017-07-24 2017-12-12 玉林市中医医院 A kind of Chinese medicine composition for treating coronary disease and angina pectoris and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1376491A (en) * 2002-04-15 2002-10-30 徐国勇 Medicine for treating myocardial infarction and angina pectoris

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1376491A (en) * 2002-04-15 2002-10-30 徐国勇 Medicine for treating myocardial infarction and angina pectoris

Also Published As

Publication number Publication date
CN101843661A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN100382839C (en) Chinese-medicinal composition for treating coronary heart disease
CN102198241B (en) Medicine for alleviating nervousness and taking care of sub-health
CN1994451A (en) Chinese medicinal composition for treating depression, its preparation method and application
CN102406911B (en) Chinese medicine preparation for treating coronary heart disease
CN103405697A (en) Medicament for treating pulmonary tuberculosis
CN103142865A (en) Traditional Chinese medicine for treating hypertension
CN101822789B (en) Hypotensor treating essential hypertension
CN101530579B (en) A pharmaceutical composition for soothing the nerves
CN102526276B (en) Anti-hypertension medicinal composition and preparation method for same
CN101711847B (en) Oral traditional Chinese medicine preparation for treating melancholia and anxiety neurosis
CN102114231B (en) Medicine for treating arrhythmia
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN101780223A (en) Traditional Chinese medicine with integral coordination function for treating ischemic cerebrovascular disease
CN102327405A (en) Chinese medicine for treating diabetic peripheral neuropathy
CN101843661B (en) Chinese medicament for treating angina
CN1290545C (en) Medicine for curing coronary heart disease
CN101940674A (en) Chinese medicament for treating diabetic peripheral neuropathy
CN103041132A (en) Chinese herbal medicine for treating insomnia
CN102327411A (en) Traditional Chinese medicine for treating diabetic gastroparalysis
CN101406594B (en) Chinese medicine for treating tumor of lung
CN101530461B (en) Traditional Chinese medicine for treating nasopharyngeal cancer
CN101843690B (en) Chinese medicament for treating osteoporosis
CN101530508B (en) Traditional Chinese medicine for treating ovarian cancer

Legal Events

Date Code Title Description
PB01 Publication
C06 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
C14 Grant of patent or utility model
TR01 Transfer of patent right

Effective date of registration: 20141218

Address after: 541105, room 2, unit 8, 1 Xing Xing Road, 202 Town, Lingui County, the Guangxi Zhuang Autonomous Region, Lingui

Patentee after: Wei Dezong

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

ASS Succession or assignment of patent right

Owner name: WEI DEZONG

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20141218

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 541105 GUILIN, GUANGXI ZHUANG AUTONOMOUS REGION

DD01 Delivery of document by public notice

Addressee: Wei Dezong

Document name: Notification to Pay the Fees

Addressee: Wei Dezong

Document name: Notification to Pay the Fees

DD01 Delivery of document by public notice
DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Wei De Zong

Document name: Notification of Termination of Patent Right

Addressee: Wei De Zong

Document name: Notification of Termination of Patent Right

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110810

Termination date: 20180925